Application 212436
- Type
- NDA
- Sponsor
- PFIZER INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBRANCE | PALBOCICLIB | TABLET;ORAL | 75MG | Yes | No |
| 002 | IBRANCE | PALBOCICLIB | TABLET;ORAL | 100MG | Yes | No |
| 003 | IBRANCE | PALBOCICLIB | TABLET;ORAL | 125MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212436-001 | IBRANCE | PALBOCICLIB | 75MG | TABLET / ORAL | RLD | 2019-11-01 | |
| N212436-002 | IBRANCE | PALBOCICLIB | 100MG | TABLET / ORAL | RLD | 2019-11-01 | |
| N212436-003 | IBRANCE | PALBOCICLIB | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212436-001 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | |
| N212436-001 | RE47739*PED | 2027-09-05 | Pediatric extension | ||
| N212436-001 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | |
| N212436-001 | 10723730*PED | 2034-08-08 | Pediatric extension | ||
| N212436-001 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | |
| N212436-001 | 11065250*PED | 2037-02-19 | Pediatric extension | ||
| N212436-002 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | |
| N212436-002 | RE47739*PED | 2027-09-05 | Pediatric extension | ||
| N212436-002 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | |
| N212436-002 | 10723730*PED | 2034-08-08 | Pediatric extension | ||
| N212436-002 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | |
| N212436-002 | 11065250*PED | 2037-02-19 | Pediatric extension | ||
| N212436-003 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | |
| N212436-003 | RE47739*PED | 2027-09-05 | Pediatric extension | ||
| N212436-003 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | |
| N212436-003 | 10723730*PED | 2034-08-08 | Pediatric extension | ||
| N212436-003 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | |
| N212436-003 | 11065250*PED | 2037-02-19 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N212436-001 | M-14 | 2028-09-16 |
| N212436-001 | PED | 2029-03-16 |
| N212436-002 | M-14 | 2028-09-16 |
| N212436-002 | PED | 2029-03-16 |
| N212436-003 | M-14 | 2028-09-16 |
| N212436-003 | PED | 2029-03-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | RLD | 2019-11-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | RLD, RS | 2019-11-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-002 | IBRANCE | 100MG | TABLET / ORAL | AB | RLD | 2019-11-01 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-003 | IBRANCE | 125MG | TABLET / ORAL | AB | RLD, RS | 2019-11-01 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N212436-001 | IBRANCE | 75MG | TABLET / ORAL | RLD | 2019-11-01 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212436-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212436-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212436-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212436-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212436-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212436-003 | AB | 1 | 1e350fbaab3a… |
| 2023-12-20 04:57 UTC | 2023-12 | N212436-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N212436-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N212436-003 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212436-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212436-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212436-003 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212436-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212436-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212436-003 | AB | 1 | 9b2671bbb829… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | RE47739*PED | 2027-09-05 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | 10723730*PED | 2034-08-08 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | 11065250*PED | 2037-02-19 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | RE47739*PED | 2027-09-05 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | 10723730*PED | 2034-08-08 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | 11065250*PED | 2037-02-19 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | RE47739*PED | 2027-09-05 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | 10723730*PED | 2034-08-08 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | 11065250*PED | 2037-02-19 | Pediatric extension | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | RE47739*PED | 2027-09-05 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | 10723730*PED | 2034-08-08 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | 11065250*PED | 2037-02-19 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | RE47739*PED | 2027-09-05 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | 10723730*PED | 2034-08-08 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | 11065250*PED | 2037-02-19 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | RE47739*PED | 2027-09-05 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | 10723730*PED | 2034-08-08 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | 11065250*PED | 2037-02-19 | Pediatric extension | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N212436-001 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-001 | 10723730 | 2034-02-08 | Drug substance, Drug product | 2020-08-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-001 | 11065250 | 2036-08-19 | Drug product | 2021-08-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212436-002 | RE47739 | 2027-03-05 | Drug substance, Drug product | 2019-11-26 | 6a471c1ec25d… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | M-14 | 2028-09-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-001 | PED | 2029-03-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | M-14 | 2028-09-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-002 | PED | 2029-03-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | M-14 | 2028-09-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212436-003 | PED | 2029-03-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | M-14 | 2028-09-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-001 | PED | 2029-03-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | M-14 | 2028-09-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-002 | PED | 2029-03-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | M-14 | 2028-09-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212436-003 | PED | 2029-03-16 | 31067a03dcf5… |
| 2019-12-13 00:20 UTC | 2019-12 | N212436-001 | NCE | 2020-02-03 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N212436-002 | NCE | 2020-02-03 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N212436-003 | NCE | 2020-02-03 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N212436-001 | NCE | 2020-02-03 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N212436-002 | NCE | 2020-02-03 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N212436-003 | NCE | 2020-02-03 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N212436-001 | NCE | 2020-02-03 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N212436-002 | NCE | 2020-02-03 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N212436-003 | NCE | 2020-02-03 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N212436-001 | NCE | 2020-02-03 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N212436-002 | NCE | 2020-02-03 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N212436-003 | NCE | 2020-02-03 | 3f01610625f2… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-001 | M-14 | 2028-09-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-001 | PED | 2029-03-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-002 | M-14 | 2028-09-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-002 | PED | 2029-03-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-003 | M-14 | 2028-09-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212436-003 | PED | 2029-03-16 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibrance | PALBOCICLIB | U.S. Pharmaceuticals | 89a142d5-7e61-48bf-9e77-e2cd124c4792 | 2026-07-06 | Warnings, Adverse reactions | 212436 NDA212436 63539-486 63539-688 63539-284 |
| Ibrance | PALBOCICLIB | Pfizer Laboratories Div Pfizer Inc | fecbdd7d-b729-41b5-9872-231b8fe104ce | 2026-07-02 | Warnings, Adverse reactions | 212436 NDA212436 0069-0486 0069-0284 0069-0688 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 63539-284 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-284 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-284 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-486 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | US Pharmaceuticals | NDA | Current |
| 63539-688 | Ibrance | palbociclib | U.S. Pharmaceuticals | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83376 | SUPPL | 2025-09-18 |
| 83374 | SUPPL | 2025-09-17 |
| 82092 | SUPPL | 2025-05-01 |
| 81968 | SUPPL | 2025-04-24 |
| 81507 | SUPPL | 2025-03-10 |
| 81478 | SUPPL | 2025-03-07 |
| 80747 | SUPPL | 2024-12-27 |
| 80710 | SUPPL | 2024-12-26 |
| 75367 | SUPPL | 2023-09-07 |
| 75366 | SUPPL | 2023-09-07 |
| 75361 | SUPPL | 2023-09-07 |
| 75360 | SUPPL | 2023-09-07 |
| 72881 | SUPPL | 2022-12-14 |
| 72878 | SUPPL | 2022-12-14 |
| 62443 | ORIG | 2020-04-06 |
| 60784 | ORIG | 2019-11-12 |
| 60778 | ORIG | 2019-11-04 |